Osaka, Japan

Yasufumi Okamura

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasufumi Okamura. Retrieved from https://idiyas.com/inventor/yasufumi-okamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Yasufumi Okamura

Introduction

Yasufumi Okamura is a notable inventor based in Osaka, Japan, recognized for his contributions to pharmaceutical innovations. With a total of three patents to his name, he has made significant advancements in the field of drug formulation.

Latest Patents

His latest patents include a pitavastatin-containing preparation and method for producing the same, which involves a unique formulation that enhances the stability and efficacy of pitavastatin. Additionally, he has developed an orally disintegrating tablet that utilizes specific saccharides and hydroxypropylcellulose, providing a novel approach to drug delivery.

Career Highlights

Yasufumi Okamura is currently employed at Sawai Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the development of pharmaceutical products. His work focuses on improving drug formulations to enhance patient compliance and therapeutic outcomes.

Collaborations

Throughout his career, Okamura has collaborated with esteemed colleagues, including Nobuko Hamaguchi and Shouichi Hosaka, fostering a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yasufumi Okamura's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his commitment to advancing medical science and improving patient care. His work continues to impact the industry positively, making him a significant figure in the realm

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…